Section d4, expiration date was updated.Both samples were received for investigation and tested with the elecsys toxo igg assay, an in-house neutralization assay, and a competitor toxo igg assay.The samples were also tested for elecsys toxo igg avidity and elecsys toxo igm.For patient 1: the elecsys toxo igg result was 83.8 iu/ml (positive).The sample was neutralizable (10.0% of remaining titer).Recomline blot toxo igg: positive.Elecsys toxo igg avidity: 92% (high avidity).Elecsys toxo igm: 0.222 coi (negative).For patient 2: the elecsys toxo igg result was 34.1 iu/ml (positive).The sample was neutralizable (10.7% of remaining titer).Recomline blot toxo igg: positive.Elecsys toxo igg avidity: 60% (low avidity).Elecsys toxo igm: 0.232 coi (negative).The customer's positive toxo igg results were reproduced during the investigation.Based on the results produced during the investigation, the samples were assessed to be correctly positive.The reagent performed within specification.The investigation did not identify a product problem.
|